ABSTRACT -Background: Temporal trends in the female population submitted to percutaneous coronary intervention were evaluated as to clinical, angiographic and procedural aspects, based on analysis of 10-year results of a national registry. The objective of this study was to compare the in-hospital results and clinical outcomes by grouping the sample into three different time frames. Methods: The database used was the Central Nacional de Intervenções Cardiovasculares (CENIC). A total of 59,931 women undergoing percutaneous coronary intervention between 2006 and 2016 were assessed and divided into timeframes, analyzing clinical and angiographic variables, as well as in-hospital outcomes. Results: There was a decrease in prevalence of smoking, hypertension, and dyslipidemia over time. Likewise, the prevalence of calcified lesions, thrombotic lesions and bifurcations decreased. The success of the procedure increased and there was a decrease in post-procedure complications, such as death, infarction or emergency surgical revascularization. In the analysis of predictors of risk of death, patients with left main coronary artery lesion presented a 15-fold risk of death (p<0.0001), and multi-vessel lesions increased the risk approximately three times (p<0.0001). Conclusion: Percutaneous coronary intervention in women presented better results along the analyzed period, with higher procedural success rates and lower rates of in-hospital complications.
less use of revascularization strategies as compared to men. [1] [2] [3] [4] Regardless of sex, percutaneous coronary intervention (PCI) offers well-established benefits in such cases, by reducing fatal and nonfatal ischemic complications in patients with acute coronary syndrome (ACS), and relieving symptoms and improving quality of life in patients with stable CAD. [2] [3] [4] [5] [6] [7] [8] Although there are few studies specifically designed to assess the results of PCI in women, several manuscripts reported differences in outcomes between males and females undergoing coronary revascularization; they mainly demonstrated procedures in female patients would be more associated with adverse events. However, there are controversies in this regard, and the reasons for the differences in results are most likely multifactorial. 1, 4, 6 This study evaluated the temporal trends in a female population submitted to PCI in relation to clinical, angiographic and procedural aspects, based on a 10-year analysis of a national registry. Our objective was to compare the in-hospital clinical results and outcomes by dividing the sample into three time frames.
METHODS
All data used in the study derived from the registry of the Central Nacional de Intervenções Cardiovasculares (CENIC; http://www.corehemo.net/). This database was established by the Sociedade Brasileira de Hemodinâmica e Cardiologia Intervencionista (SBHCI), in 1991, and gathers information on PCI procedures, with data provided voluntarily by physicians, who are members of several Brazilian centers. 2 The CENIC registry form for PCI contains information on risk factors for ischemic heart disease, clinical aspects, technical details of the procedure, and in-hospital clinical results. Data are sent online, through standardized forms, and periodically updated. 3 The CENIC encompasses the following variables: age, sex, risk factors for cardiovascular disease (diabetes mellitus, hypertension, smoking, dyslipidemia and family history of CAD), clinical presentation and indication of PCI, ventricular function, number of vessels involved, vessel submitted to intervention, lesion characteristics, success rate and complications (death, vascular complications, infarction or kidney failure after PCI). The clinical status is classified as asymptomatic, stable angina, myocardial infarction (MI) or non-ST segment elevation ACS (NSTE-ACS).
When classifying death, any type -of cardiovascular origin or not -was considered. Major adverse cardiac events (MACE) included death, nonfatal MI, or urgent revascularization. All women who underwent PCI between June 2006 and March 2016 were included. A total of 59,931 female patients were included. The registry followed all ethical precepts provided by the Brazilian laws, and all patient data were kept confidential.
This study was evaluated and approved by the Research Ethics Committee of Hospital Leforte and was registered in Plataforma Brasil, CAAE: 09029919.4.0000.5485.
Statistical analysis
Patients were divided into three time frames -2006 to 2008, 2009 to 2011 and 2012 to 2016. The Chi-square test and analysis of variance (ANOVA) were used to compare the categorical and continuous variables, respectively. Whenever necessary, the likelihood ratio test was used. For multiple comparisons, the Bonferroni correction was employed. To verify the influence of variables of interest in relation to mortality, simple and bivariate logistic regression models were used. For all analyses, the significance level was set at 5% (p<0.05).
RESULTS
The mean age of patients was 65 years. In this population there was a decrease throughout the years in the prevalence of smoking (p<0.0001), hypertension (p<0.0001), dyslipidemia (p=0.0003) and previous coronary artery bypass grafting (CABG) (p<0.0001). It was noted, however, that patients in the 2012-2016 interval presented a higher prevalence of prior MI (p<0.0001), previous PCI (p<0.0001), and unstable clinical conditions (p <0.0001), as compared to other two periods. The clinical characteristics are detailed in table 1. Table 2 depicts the angiographic characteristics of the sample studied. There was a significant difference in the extent of CAD between the years studied. Over time, there was an increase in single-vessel lesions (p<0.0001) and left ventricular dysfunction. The prevalence of calcified (p<0.0001) and thrombotic (p<0.0001) lesions, as well as of bifurcations (p<0.0001) decreased. There were no differences among the periods regarding the approach of chronic total occlusions (p=0.2277).
The treated vessels/patient ratio was the same in the three periods. The mean stent diameter (p<0.0001), primary PCI rates (p<0.0001) and use of glycoprotein IIb/IIIa inhibitors (p<0.0001) decreased over time. The mean stent length (p<0.0001) and use of drug-eluting stents (p<0.0001) considerably increased throughout the periods, as well as the final procedural success rate ( Table 3) .
The clinical outcomes analyzed are described in table 4. Periprocedural MI decreased over the periods (p=0.0005). The other in-hospital clinical outcomes -emergency CABG (p=0.0042), death (p=0.0050) and MACE (p<0.0001) -also dropped over the years.
In the analysis of risk predictors for post-PCI death, variables that impacted on this outcome were identified (Table 5 Results expressed as mean ± standard deviation or n (%). PCI: percutaneous coronary intervention. Results expressed as n (%). MI: myocardial infarction; CABG: coronary artery bypass surgery; MACE: major adverse cardiac events. 
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of target lesion revascularization, and of definitive or probable stent thrombosis. 9 Analyzing other variables, such as frequency of primary PCI, we noted its drop over the years. The literature, however, has shown the number of cases of primary PCI has increased for both men and women. 4 One possible explanation for this discrepancy is that primary PCI is notoriously underreported in our country, since many catheterization centers do not systematically record these data. Regarding glycoprotein IIb/IIIa inhibitors, there was a progressive reduction in their use. The decrease over time may be due to the lack of evidence to support the routine use of the drug for both sexes, although it is still accepted in selected cases. 11, 12 The procedural success increased, consonant with reduced MACE, which showed a progressive decline over time.
The increase in success rates in this female population is presumed to be directly related to the evolution of PCI since the beginning of its practice. First, the limitations of balloon angioplasty were overcome with the introduction of stents, which presented lower rates of restenosis, but early thrombosis and neointimal hyperplasia were still hindrances. With the launching of DES, which are equally safe and effective in women and men, the restenosis rates were significantly reduced. In addition, the increased success rates can be attributed not only to the progress of technology applied to catheters, balloons, and stents, but also to important advances in intracoronary imaging methods and associated pharmacology.
13,14
Limitations
This is an observational, retrospective, multicenter study, with data provided voluntarily by different healthcare professionals; therefore some data may have not been systematically filled in, or may even been omitted. The total number of participants may be underestimated, although it represents the largest series ever published in Brazil about the topic.
CONCLUSION
Percutaneous coronary intervention in women registered at CENIC presented better results over the last decade, with higher procedural success rates and less in-hospital complications. Hypertension, emergency procedures and multivessel coronary artery disease were independent predictors of higher in-hospital mortality in this population.
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The authors declare no conflicts of interest. et al., who evaluated clinical outcomes in approximately 6.6 million patients undergoing PCI in the United States, our in-hospital mortality rate was lower than that reported for females (2%), and closer to that for males (1.4%). 4 These data suggest that PCI is also a safe and effective procedure in females.
The age profile remained similar during the 10 years analyzed. It is well-known that women who undergo PCI have some peculiarities regarding morbidity and mortality. They are, on average, 4.5 years older than men and present more risk factors, such as heart and kidney failure, diabetes mellitus, anemia, dyslipidemia, and hypertension. 5 However, there was a reduction in patients with hypertension, dyslipidemia, smoking habits and previous CABG. There was also a positive association between the risk of death and diagnosis of hypertension, presence of two-or three-vessel disease and LMCA lesions, and non-elective PCI. Thus, the reduction of comorbidities and of the multi-arterial involvement may be associated with improved clinical outcomes in the two final periods.
In the analysis of complexity of lesions and extent of coronary artery disease, there was an increase in the singlevessel lesions and lower prevalence of calcified, thrombotic, and bifurcation lesions. The anatomical complexity of lesions is also a factor that influences the outcome of PCI. Women often have small caliber and more tortuous coronary arteries. Some studies showed higher procedure-related complication rates in women, including hypotension, bleeding, and need for blood transfusion or vascular repair, and that this population also presents with a higher risk of coronary artery dissection and perforation. 6, 7 Knowledge of these peculiarities related to women, together with reduced complexity and extent of the disease, would also explain the better clinical outcomes over the years.
We found a reduction in the diameter and an increase in the length of stents along time. According to Sipahi et al., the female population has smaller caliber vessels, with different anatomical characteristics, requiring a technical adaptation of balloon and stent sizes. 8 Considering the substantially greater risk of restenosis in thin vessels, drug-eluting stents (DES) are indicated in this context, and enable addressing longer coronary segments as compared to bare-metal stents (BMS). Moreover, DES present lower rates of restenosis and target vessel revascularization. 9 The use of drug-eluting stents was higher in 2012-2016 than in other periods. This finding is consistent with a publication by Bangalore et al., showing that in the American population at risk of restenosis, including females, DES accounted for 73% of devices implanted in the United States as from 2011. 10 This prevalence may be due to the evolution of the new generation DES, which were analyzed by Giustino et al., in women referred for complex PCI. These authors demonstrated that their use was associated with a lower risk of MACE within 3 years,
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